Class Rep Pushes To Kill Deal Over Chemo Drug Sales

Law360, New York (March 28, 2011, 2:27 PM EDT) -- With the fate of his attorney still pending before the First Circuit, the representative of a consumer class allegedly overcharged for chemotherapy drugs lodged a last-ditch attempt Friday to disqualify the lead class counsel and kill a proposed settlement agreement.

Counsel in the average wholesale price multidistrict litigation could have signed off on a 2007 settlement deal that would have delivered $13 million to a class of Medicare beneficiaries who bought allegedly overpriced chemotherapy drugs through Bristol-Myers Squibb Co., according to a motion to disqualify those...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.